Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

U.S. CDC Says Delivered 578,263,565 Doses Of COVID-19 Vaccine As Of Dec 2

12/02/2021 | 05:18pm EST

Dec 2 (Reuters) - U.S. CDC:

* U.S. CDC SAYS DELIVERED 578,263,565 DOSES OF COVID-19 VACCINE AS OF DEC 2 VERSUS 575,721,925 DOSES AS OF DEC 1

* U.S. CDC SAYS 234,269,053 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF DEC 2 VERSUS 233,590,555 INDIVIDUALS AS OF DEC 1

* U.S. CDC SAYS ADMINISTERED 464,445,580 DOSES OF COVID-19 VACCINE AS OF DEC 2 VERSUS 462,263,845 DOSES AS OF DEC 1

* U.S. CDC SAYS 197,838,728 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF DEC 2 VERSUS 197,363,116 INDIVIDUALS AS OF DEC 1

* U.S. CDC SAYS AS OF DECEMBER 2, 42,973,222 PEOPLE RECEIVED A BOOSTER DOSE FOR COVID-19 VACCINE SINCE AUGUST 13, 2021


ę Reuters 2021
All news about MODERNA, INC.
09:38aModerna, IAVI Say Clinical Trial of Experimental HIV Vaccine Antigens is Underway
MT
09:19aMODERNA : IAVI and Moderna Launch Trial of HIV Vaccine Antigens Delivered Through mRNA Tec..
PU
09:09aWALL STREET STOCK EXCHANGE : Are we still in the Goldilocks zone?
08:57aMARKETSCREENER'S WORLD PRESS REVIEW : January 27, 2022
01/26Pfizer-BioNTech, Moderna COVID-19 Jabs Shown Safe For Women Undergoing IVF in Study
MT
01/26Moderna Launches Mid-Stage Study of Omicron-Specific Booster Jab
MT
01/26Moderna starts trial for Omicron-specific booster shot
RE
01/26Moderna starts trial testing Omicron-specific booster shot
RE
01/26MODERNA : Announces First Participant Dosed in Phase 2 Study of Omicron-Specific Booster C..
PU
01/26Moderna begins testing omicron-matched COVID shots in adults
AQ
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 17 766 M - -
Net income 2021 11 257 M - -
Net cash 2021 11 938 M - -
P/E ratio 2021 5,59x
Yield 2021 -
Capitalization 60 258 M 60 258 M -
EV / Sales 2021 2,72x
EV / Sales 2022 1,72x
Nbr of Employees 1 300
Free-Float 90,5%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 148,62 $
Average target price 262,47 $
Spread / Average Target 76,6%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-41.48%62 828
LONZA GROUP AG-20.54%48 784
IQVIA HOLDINGS INC.-17.54%44 443
SEAGEN INC.-20.08%22 592
ICON PUBLIC LIMITED COMPANY-18.28%20 601
CELLTRION, INC.-25.51%18 165